Cargando…
Exosomes and osteosarcoma drug resistance
Osteosarcoma (OS) is a primary malignant tumor of bone characterized by the formation of bone tissue or immature bone by tumor cells. Because of its multi-drug resistance, even with the improvement of chemotherapy and the use of targeted drugs, the survival rate of osteosarcoma (OS) is still less th...
Autores principales: | Fu, Huichao, Wu, Yunjiao, Chen, Jianbai, Hu, Xing, Wang, Xiaoyan, Xu, Gongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064327/ https://www.ncbi.nlm.nih.gov/pubmed/37007086 http://dx.doi.org/10.3389/fonc.2023.1133726 |
Ejemplares similares
-
Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
por: Hu, Xin, et al.
Publicado: (2022) -
The Role of Exosomal microRNA in Cancer Drug Resistance
por: Guo, Qiao-ru, et al.
Publicado: (2020) -
Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma
por: Wang, Li, et al.
Publicado: (2021) -
Exosomes: A New Pathway for Cancer Drug Resistance
por: Zhong, Yunbin, et al.
Publicado: (2021) -
Exosomal MiR-199a-5p Inhibits Tumorigenesis and Angiogenesis by Targeting VEGFA in Osteosarcoma
por: Zhang, Lu, et al.
Publicado: (2022)